nanotech-investing Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International Conference
nanotech-investing Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights